Literature DB >> 24535463

Dementia: Mild cognitive impairment--not always what it seems.

Edo Richard1, Carol Brayne2.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 24535463     DOI: 10.1038/nrneurol.2014.23

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

1.  Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force.

Authors:  Bruno Vellas; Maria C Carrillo; Cristina Sampaio; H Robert Brashear; Eric Siemers; Harald Hampel; Lon S Schneider; Michael Weiner; Rachelle Doody; Zaven Khachaturian; Jesse Cedarbaum; Michael Grundman; Karl Broich; Ezio Giacobini; Bruno Dubois; Reisa Sperling; Gordon K Wilcock; Nick Fox; Philip Scheltens; Jacques Touchon; Suzanne Hendrix; Sandrine Andrieu; Paul Aisen
Journal:  Alzheimers Dement       Date:  2013-07       Impact factor: 21.566

2.  Optimizing mild cognitive impairment for discriminating dementia risk in the general older population.

Authors:  Blossom C M Stephan; George M Savva; Carol Brayne; John Bond; Ian G McKeith; Fiona E Matthews
Journal:  Am J Geriatr Psychiatry       Date:  2010-08       Impact factor: 4.105

3.  Mild cognitive impairment, incidence, progression, and reversion: findings from a community-based cohort of elderly African Americans.

Authors:  Sujuan Gao; Frederick W Unverzagt; Kathleen S Hall; Kathleen A Lane; Jill R Murrell; Ann M Hake; Valerie Smith-Gamble; Hugh C Hendrie
Journal:  Am J Geriatr Psychiatry       Date:  2013-07-03       Impact factor: 4.105

4.  Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal.

Authors:  Rosebud O Roberts; David S Knopman; Michelle M Mielke; Ruth H Cha; V Shane Pankratz; Teresa J H Christianson; Yonas E Geda; Bradley F Boeve; Robert J Ivnik; Eric G Tangalos; Walter A Rocca; Ronald C Petersen
Journal:  Neurology       Date:  2013-12-18       Impact factor: 9.910

5.  Screening for dementia--is it a no brainer?

Authors:  C Fox; L Lafortune; M Boustani; T Dening; G Rait; C Brayne
Journal:  Int J Clin Pract       Date:  2013-08-16       Impact factor: 2.503

Review 6.  Mild cognitive impairment as a diagnostic entity.

Authors:  R C Petersen
Journal:  J Intern Med       Date:  2004-09       Impact factor: 8.989

7.  Revising the definition of Alzheimer's disease: a new lexicon.

Authors:  Bruno Dubois; Howard H Feldman; Claudia Jacova; Jeffrey L Cummings; Steven T Dekosky; Pascale Barberger-Gateau; André Delacourte; Giovanni Frisoni; Nick C Fox; Douglas Galasko; Serge Gauthier; Harald Hampel; Gregory A Jicha; Kenichi Meguro; John O'Brien; Florence Pasquier; Philippe Robert; Martin Rossor; Steven Salloway; Marie Sarazin; Leonardo C de Souza; Yaakov Stern; Pieter J Visser; Philip Scheltens
Journal:  Lancet Neurol       Date:  2010-10-09       Impact factor: 44.182

8.  Factors predicting reversion from mild cognitive impairment to normal cognitive functioning: a population-based study.

Authors:  Perminder S Sachdev; Darren M Lipnicki; John Crawford; Simone Reppermund; Nicole A Kochan; Julian N Trollor; Wei Wen; Brian Draper; Melissa J Slavin; Kristan Kang; Ora Lux; Karen A Mather; Henry Brodaty
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

9.  MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy study.

Authors:  Edo Richard; Ben A Schmand; Piet Eikelenboom; Willem A Van Gool
Journal:  BMJ Open       Date:  2013-06-20       Impact factor: 2.692

10.  Rate of conversion from prodromal Alzheimer's disease to Alzheimer's dementia: a systematic review of the literature.

Authors:  Alex Ward; Sarah Tardiff; Catherine Dye; H Michael Arrighi
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2013-09-28
  10 in total
  6 in total

Review 1.  Osteoporosis and alzheimer pathology: Role of cellular stress response and hormetic redox signaling in aging and bone remodeling.

Authors:  Carolin Cornelius; Guido Koverech; Rosalia Crupi; Rosanna Di Paola; Angela Koverech; Francesca Lodato; Maria Scuto; Angela T Salinaro; Salvatore Cuzzocrea; Edward J Calabrese; Vittorio Calabrese
Journal:  Front Pharmacol       Date:  2014-06-10       Impact factor: 5.810

2.  Longitudinal changes in task-evoked brain responses in Parkinson's disease patients with and without mild cognitive impairment.

Authors:  Urban Ekman; Johan Eriksson; Lars Forsgren; Magdalena E Domellöf; Eva Elgh; Anders Lundquist; Lars Nyberg
Journal:  Front Neurosci       Date:  2014-07-29       Impact factor: 4.677

3.  Cognitive Ageing in Great Britain in the New Century: Cohort Differences in Episodic Memory.

Authors:  Gindo Tampubolon
Journal:  PLoS One       Date:  2015-12-29       Impact factor: 3.240

4.  Are We There Yet? Exploring the Impact of Translating Cognitive Tests for Dementia Using Mobile Technology in an Aging Population.

Authors:  Kai Ruggeri; Áine Maguire; Jack L Andrews; Eric Martin; Shantanu Menon
Journal:  Front Aging Neurosci       Date:  2016-03-17       Impact factor: 5.750

5.  Prolonged or serious conflicts at work and incident dementia: a 23-year follow-up of the Copenhagen City Heart Study.

Authors:  Kazi Ishtiak-Ahmed; Åse Marie Hansen; Erik Lykke Mortensen; Anne Helene Garde; Ane Nørgaard; Finn Gyntelberg; Naja Hulvej Rod; Sabrina Islamoska; Rikke Lund; Thien Kieu Thi Phung; Eva Prescott; Gunhild Waldemar; Kirsten Nabe-Nielsen
Journal:  Int Arch Occup Environ Health       Date:  2018-10-28       Impact factor: 3.015

6.  Are large simple trials for dementia prevention possible?

Authors:  William N Whiteley; Sonia Anand; Shrikant I Bangdiwala; Jackie Bosch; Michelle Canavan; Howard Chertkow; Hertzel C Gerstein; Philip Gorelick; Martin O'Donnell; Guillaume Paré; Marie Pigeyre; Sudha Seshadri; Mike Sharma; Eric E Smith; Jeff Williamson; Tali Cukierman-Yaffe; Robert G Hart; Salim Yusuf
Journal:  Age Ageing       Date:  2020-02-27       Impact factor: 10.668

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.